Compounds > 6-amino-1-hydroxyhexane-1,1-diphosphonate
Page last updated: 2024-08-25

6-amino-1-hydroxyhexane-1,1-diphosphonate and Algodystrophic Syndrome

6-amino-1-hydroxyhexane-1,1-diphosphonate has been researched along with Algodystrophic Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adami, S; Gatti, D; Idolazzi, L; Malavolta, N; Rossini, M; Sinigaglia, L; Varenna, M; Zucchi, F1

Trials

1 trial(s) available for 6-amino-1-hydroxyhexane-1,1-diphosphonate and Algodystrophic Syndrome

ArticleYear
Treatment of complex regional pain syndrome type I with neridronate: a randomized, double-blind, placebo-controlled study.
    Rheumatology (Oxford, England), 2013, Volume: 52, Issue:3

    Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Double-Blind Method; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pain Measurement; Reflex Sympathetic Dystrophy; Treatment Outcome

2013